Mercer Global Advisors
ZURA icon

Mercer Global Advisors’s Zura Bio ZURA Stock Holding History

Mercer Global Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55K Buy
+1,110
New +$5.29K ﹤0.01% 5267

Other funds holding ZURA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Mercer Global Advisors's ZURA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Zura Bio (ZURA) in Q2 2026: 1,110 shares worth $6.55K. The stake represents ﹤0.01% of the portfolio and ranks #5267 among its holdings.

50 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Mercer Global Advisors held 1,110 shares of Zura Bio worth $6.55K as of Q2 2026.
  • Zura Bio was a new Mercer Global Advisors position in Q2 2026.
  • Zura Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5267 holding.
  • 50 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.